Abstract:BACKGROUND: Malignant obstructive jaundice is mainly caused by cholangiocarcinoma. Only a few patients are indicated for surgical resection, and the 3-year survival rate is < 50%. For patients who are not eligible for surgery, biliary stent placement can relieve biliary obstruction and improve liver function and quality of life. However, restenosis after biliary stents has a poor prognosis and is a clinical challenge. Biliary stent combined with iodine-125 (125I) seed implantation can prolong stent patency and improve survival.AIM: To evaluate the safety and efficacy of biliary stent combined with 125I seed strand implantation in malignant obstructive jaundice.METHODS: We enrolled 67 patients between January 2016 and June 2018 with malignant obstructive jaundice and randomized them into a biliary stent combined with 125I seed strand treatment (combined) group (n = 32) and biliary stent (control) group (n = 35). All patients underwent enhanced computed tomography and magnetic resonance imaging and were tested for biochemical and cancer markers. Twelve patients underwent pathological examination before surgery. All patients were followed up by telephone or clinical visit. Postoperative liver function improvement, postoperative complications, stent patency time, and survival time were compared between the two groups. Prognostic risk factors were evaluated.RESULTS: Technical success was achieved in all patients in both groups. Postoperative liver function improved significantly in all patients (total bilirubin, direct bilirubin, alanine aminotransferase, and aspartate aminotransferase decreased significantly in all patients, the P values were less than 0.05). There was no significant difference in preoperative or postoperative indexes between the two groups for changes in total bilirubin (P = 0.147), direct bilirubin (P = 0.448), alanine aminotransferase (P = 0.120), and aspartate aminotransferase (P = 0.387) between the two groups. The median stent patency time of the combined group was 9.0 ± 1.4 mo [95% confidence interval (CI): 6.3-11.8 mo], which was significantly longer than the that of the control group (6.0 ± 0.3 mo, 95%CI: 5.5-6.5 mo, P = 0.000). The median survival time of the combined group was 11.0 ± 1.4 mo (95%CI: 8.2-13.7 mo), which was significantly longer than that of the control group (7.0 ± 0.3 mo, 95%CI: 6.4-7.6 mo, P = 0.000). Location of obstruction and number of stents were independent risk factors affecting prognosis.CONCLUSION: Biliary stent combined with 125I seed strand implantation is safe and effective in malignant obstructive jaundice and improves stent patency time and median survival time.

HDR-^192Ir Intraluminal Brachytherapy in Treatment of Malignant Obstructive Jaundice

Comparison of Intraluminal Brachytherapy Combined with and Without Stent Placement for Treatment of Obstructive Jaundice Induced by Tumor Thrombus.

The Use of 125I Seed Strands for Intraluminal Brachytherapy of Malignant Obstructive Jaundice

Malignant Obstructive Jaundice Treated with Intraluminal Placement of Iodine-125 Seed Strands and Metal Stents: an Analysis of Long-Term Outcomes and Prognostic Features

Malignant Obstructive Jaundice Treated by Intraluminal Brachytherapy Combined with Stent Placement or Stent Implantation Alone

Malignant obstructive jaundice - brachytherapy as a tool for palliation

Percutaneous Drainage and Stenting for Treatment of Malignant Obstruction of Bile Duct

Preliminary application of brachytherapy with double-strand 125I seeds and biliary drainage for malignant obstructive jaundice

Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice

A Pilot Study of Intraluminal Brachytherapy Using 125I Seed Strand for Locally Advanced Pancreatic Ductal Adenocarcinoma with Obstructive Jaundice.

Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: a multicentre trial.

The Clinical Observation of Interventional Therapy for Malignant Obstructive Jaundice

Biliary stent with or without 125 I seeds for malignant obstructive jaundice : a systematic review and meta-analysis

Biliary Stent With Or Without I-125 Seeds For Malignant Obstructive Jaundice: A Systematic Review And Meta-Analysis

Iodine-125 Seeds Combined with Biliary Stent Placement Versus Stent Placement Alone for Unresectable Malignant Biliary Obstruction: A Meta-Analysis of Randomized Controlled Trials

Damage to Pig Bile Duct Caused by Intraluminal Brachytherapy Using a (125)I Ribbon.

Palliative treatment for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of self-expandable metallic stents

Percutaneous Transhepatic Biliary Drainage and Stenting for Malignant Obstructive Jaundice: A Report of Two Cases

Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma

Preliminary Results of a Phase 1/2 Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non–small Cell Lung Canc

Hepatic arterial infusion chemotherapy following simultaneous metallic stent placement and iodine-125 seed strands for advanced cholangiocarcinoma causing malignant obstructive jaundice: a propensity score matching study